Inventor
LUENGO JUAN
US16 patents
⚠️ This page may combine multiple inventors who share the name “LUENGO JUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PRELUDE THERAPEUTICS INC
11 patentsUS11208416B2Dec 28, 2021
Selective inhibitors of protein arginine methytransterase 5 (PRMT5)
PRELUDE THERAPEUTICS INC1 citations72
US10570140B2Feb 25, 2020
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
PRELUDE THERAPEUTICS INC4 citations72
US11254683B2Feb 22, 2022
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
PRELUDE THERAPEUTICS INC3 citations71
US11214574B2Jan 4, 2022
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
PRELUDE THERAPEUTICS INC3 citations71
US10711007B2Jul 14, 2020
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
PRELUDE THERAPEUTICS INC6 citations71
US12459950B2Nov 4, 2025
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
PRELUDE THERAPEUTICS INC0 citations61
US11078205B2Aug 3, 2021
Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)
PRELUDE THERAPEUTICS INC0 citations61
US11524962B2Dec 13, 2022
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)
PRELUDE THERAPEUTICS INC0 citations51
US12440506B2Oct 14, 2025
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
PRELUDE THERAPEUTICS INC0 citations47
US11220524B2Jan 11, 2022
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
PRELUDE THERAPEUTICS INC0 citations47
US11130769B2Sep 28, 2021
Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein
PRELUDE THERAPEUTICS INC0 citations47